We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

28 hedge funds and large institutions have $34.2K invested in Ampio Pharmaceuticals Inc. in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

3% less funds holding

Funds holding: 29 → 28 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

67% less capital invested

Capital invested by funds: $102K → $34.2K (-$68.3K)

Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$33.1K
2
Morgan Stanley
Morgan Stanley
New York
+$3.97K
3
TRCT
Tower Research Capital (TRC)
New York
+$2.18K
4
UBS Group
UBS Group
Switzerland
+$2.15K
5
KIG
Kessler Investment Group
Indiana
+$7

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$40.1K
2
HF
HRT Financial
New York
-$36K
3
Wells Fargo
Wells Fargo
California
-$57
4
CCMW
Cypress Capital Management (Wyoming)
Wyoming
-$10
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$18K +$33.1K +19,103 New
Morgan Stanley
2
Morgan Stanley
New York
$7.18K +$3.97K +2,295 +42%
TRCT
3
Tower Research Capital (TRC)
New York
$3.25K +$2.18K +1,258 +55%
CFO
4
CVA Family Office
Colorado
$2.9K – – –
UBS Group
5
UBS Group
Switzerland
$1.15K +$2.15K +1,242 +31,050%
CCMW
6
Cypress Capital Management (Wyoming)
Wyoming
$424 -$10 -6 -1%
Osaic Holdings
7
Osaic Holdings
Arizona
$379 – – –
GIA
8
GHP Investment Advisors
Colorado
$276 – – –
SS
9
Sunbelt Securities
Texas
$190 – – –
JP Morgan Chase
10
JP Morgan Chase
New York
$93 – – –
JWA
11
JFS Wealth Advisors
Pennsylvania
$77 – – –
JWM
12
Janiczek Wealth Management
Colorado
$52 – – –
Bank of America
13
Bank of America
North Carolina
$39 – – –
Group One Trading
14
Group One Trading
Illinois
$32 – – –
NFSG
15
Newbridge Financial Services Group
Florida
$32 – – –
Northwestern Mutual Wealth Management
16
Northwestern Mutual Wealth Management
Wisconsin
$24 – – –
FFA
17
Farther Finance Advisors
California
$14 – – –
SWM
18
Sanctuary Wealth Management
Idaho
$13 – – –
AF
19
Allworth Financial
California
$10 – – –
AAP
20
Arax Advisory Partners
Colorado
$10 – – –
Wells Fargo
21
Wells Fargo
California
$6 -$57 -33 -85%
CTB
22
Country Trust Bank
Illinois
$6 – – –
MBFW
23
Morton Brown Family Wealth
Pennsylvania
$6 – – –
GEA
24
Glen Eagle Advisors
New Jersey
$4 – – –
KIG
25
Kessler Investment Group
Indiana
$4 +$7 +4 New
1
2

AMPE Hedge Fund Activity: Q1 2024 in Review

28 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2024, worth a combined $34.2K — down 67% from $102K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AMPE and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $33.1K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $40.1K sold.

  • 28 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2024, down from 29 in Q4 2023.
  • Funds reported $34.2K of Ampio Pharmaceuticals Inc. stock for Q1 2024, down 67% quarter-over-quarter.
  • 2 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2024 and 3 closed out, a net change of -1 holder.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q1 2024 was Virtu Financial, an estimated $33.1K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q1 2024 was Susquehanna International Group, an estimated $40.1K sold.

Based on aggregated 13F filings for Q1 2024.